Therefore, the aim of this observational study was to assess dietary intake and adherence to the nutritional recommendations in patients with T2D treated with GLP-1 RAs, comparing them with those receiving other oral hypoglycemic agents, and eventually, to explore whether macronutrient intake varies according to the duration of GLP-1 RAs therapy. Here, GLP1R is linked to type 2 diabetes mellitus.